中文产业新闻精选评分68Chinese source
大鹏肿瘤与Cullinan宣布zipalertinib联合化疗III期REZILIENT3达到PFS主要终点
大鹏制药临床III期成功
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
大鹏制药临床III期成功
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.